Lupagen & Humanigen to explore point-of-care CAR-T therapyPR Newswire (press release)DALLAS, May 22, 2018 /PRNewswire/ — Lupagen, Inc. (www.lupagen.com), a medical device company developing first-in-class cell and gene therapy delivery technologie… Continue reading
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018GlobeNewswire (press release)CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemc… Continue reading
A new DNA editing toolkit for the alga NannochloropsisPhys.OrgThe heart of CRISPR is that it targets specific stretches of DNA for mutations. Scientists insert a gene construct – a package – in an organism. The construct includes a guiding mechanism to… Continue reading
The Conversation US |
These CRISPR-modified crops don’t count as GMOs
The Conversation US The gene editing tool we use is called CRISPR – which stands for “Clustered Regularly Interspaced Short Palindromic Repeats” – and was adapted from the defense systems of bacteria. These bacterial CRISPR systems have been modified so that scientists … CRISPR-edited rice plants produce major boost in grain yieldPhys.Org |
Endpoints News |
Hunting a cure, Spark reports steady progress on hemophilia B gene therapy as Pfizer preps for pivotal handoff
Endpoints News After some fine tuning on the manufacturing side, Spark Therapeutics $ONCE says it’s racked up a new round of promising results for its Phase I/II study of a groundbreaking new gene therapy that aims to cure hemophilia B. And the biotech is prepping a … Spark’s gene therapy SPK-9001 shows treatment benefit in hemophilia B studySeeking Alpha Spark/Pfizer eye phase 3 trial of haemophilia B gene therapypharmaphorum More encouraging data for Spark and Pfizer’s potential haemophilia B curePMLiVE |
|
TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and …
PR Newswire (press release) Padmanee Sharma, M.D., Ph.D., is a leading translational scientist and clinical investigator focused on cancer immunotherapy. Her work was critical to advancing the research and development that yielded the world’s first checkpoint inhibitors, and she … Global Cancer Immunotherapy Market 2018 Assessment- Merck, Novartis and Janssen Global ServicesBusiness Services |